相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Liquid biopsy for cancer screening Careful evaluation must consider harms as well as potential benefits
Stephen H. Bradley et al.
BMJ-BRITISH MEDICAL JOURNAL (2021)
Circulating tumor DNA methylation profiles enable early diagnosis, prognosis prediction, and screening for colorectal cancer
Huiyan Luo et al.
SCIENCE TRANSLATIONAL MEDICINE (2020)
Population Screening for Inherited Predisposition to Breast and Ovarian Cancer
Ranjit Manchanda et al.
ANNUAL REVIEW OF GENOMICS AND HUMAN GENETICS, VOL 21, 2020 (2020)
Feasibility of blood testing combined with PET-CT to screen for cancer and guide intervention
Anne Marie Lennon et al.
SCIENCE (2020)
Sensitive and specific multi-cancer detection and localization using methylation signatures in cell-free DNA
M. C. Liu et al.
ANNALS OF ONCOLOGY (2020)
Early experience with the FDA's Breakthrough Devices program
James L. Johnston et al.
NATURE BIOTECHNOLOGY (2020)
Non-invasive early detection of cancer four years before conventional diagnosis using a blood test
Xingdong Chen et al.
NATURE COMMUNICATIONS (2020)
Postmarket Clinical Evidence for High-Risk Therapeutic Medical Devices Receiving Food and Drug Administration Premarket Approval in 2010 and 2011
Vinay K. Rathi et al.
JAMA NETWORK OPEN (2020)
Cancer overdiagnosis: a biological challenge and clinical dilemma
Sudhir Srivastava et al.
NATURE REVIEWS CANCER (2019)
Digital health: a path to validation
Simon C. Mathews et al.
NPJ DIGITAL MEDICINE (2019)
Next-generation sequencing in liquid biopsy: cancer screening and early detection
Ming Chen et al.
HUMAN GENOMICS (2019)
Postmarket studies required by the US Food and Drug Administration for new drugs and biologics approved between 2009 and 2012: cross sectional analysis
Joshua D. Wallach et al.
BMJ-BRITISH MEDICAL JOURNAL (2018)
Postmarket studies required by the US Food and Drug Administration for new drugs and biologics approved between 2009 and 2012: cross sectional analysis
Joshua D. Wallach et al.
BMJ-BRITISH MEDICAL JOURNAL (2018)
Cancer genetics, precision prevention and a call to action
Clare Turnbull et al.
NATURE GENETICS (2018)
Circulating tumor DNA - Current state of play and future perspectives
Gabriele De Rubis et al.
PHARMACOLOGICAL RESEARCH (2018)
Registry-Based Prospective, Active Surveillance of Medical-Device Safety
Frederic S. Resnic et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Gene Panel Testing for Inherited Cancer Risk
Michael J. Hall et al.
JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK (2014)
Assessing the Safety and Effectiveness of Devices After US Food and Drug Administration Approval FDA-Mandated Postapproval Studies
Ian S. Reynolds et al.
JAMA INTERNAL MEDICINE (2014)
DNA methylation profiling in the clinic: applications and challenges
Holger Heyn et al.
NATURE REVIEWS GENETICS (2012)
Effectiveness-implementation Hybrid Designs Combining Elements of Clinical Effectiveness and Implementation Research to Enhance Public Health Impact
Geoffrey M. Curran et al.
MEDICAL CARE (2012)
Medicare's Coverage With Evidence Development: A Policy-Making Tool in Evolution
[Anonymous]
JOURNAL OF ONCOLOGY PRACTICE (2007)
分享论文
